×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 5: LABELLING AND NAMING FOR BIOSIMILARS: THE DEBATE CONTINUES
Session Chair(s)
Christian Schneider, DrMed
Head of Biopharma Excellence and Chief Medical Officer (Biopharma)
PharmaLex, Denmark
Speaker(s)
WHO Biological Qualifier – Recent developments and what will be the next steps?
Raffaella Giovanna Balocco Mattavelli, PharmD, PhD
World Health Organization (WHO), Switzerland
Group Lead, International Nonproprietary Name Programme
Labelling & Naming – European Biosimilars Group (EBG) perspective
Elke Grooten, MPharm
Novartis, Belgium
Head EU Relations
Labelling & Naming – European Biopharmaceutical Enterprises (EBE) perspective
Virginia Acha, PhD, MSc
Merck Sharp & Dohme LLC, United Kingdom
AVP, Global Regulatory Policy
Have an account?